O'Neill S K, Bolger G T
Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Canada.
Brain Res Bull. 1990 Jul;25(1):211-4. doi: 10.1016/0361-9230(90)90279-9.
The effects of low doses of dihydropyridine (DHP) calcium channel antagonists nimodipine, nifedipine, (-)-R-202-791, and amlodipine, the DHP calcium channel agonist BAY K 8644 were investigated on clonic convulsions to pentylenetetrazole (PTZ) in mice. Nimodipine (2-20 mg/kg) produced a dose-dependent increase in the onset time for convulsions, but did not decrease the number of mice convulsing. Nifedipine, amlodipine (10 mg/kg) and BAY K 8644 (2 mg/kg) also produced an increase in the onset time for convulsions. (-)-R-202-791 (10 mg/kg) was without effect on clonic convulsions to PTZ. BAY K 8644 increased the number of mice dying from tonic-extension convulsions to PTZ. Nimodipine did not affect convulsions elicited by strychnine. Thus, low doses of DHP calcium antagonists possess anticonvulsant properties which are structurally dependent, while DHP calcium channel activators may act to promote convulsions. These observations suggest and support previous evidence that DHP receptors are important modulatory sites for the convulsive state.
研究了低剂量二氢吡啶(DHP)钙通道拮抗剂尼莫地平、硝苯地平、(-)-R-202-791和氨氯地平以及DHP钙通道激动剂BAY K 8644对小鼠戊四氮(PTZ)所致阵挛性惊厥的影响。尼莫地平(2 - 20毫克/千克)使惊厥发作时间呈剂量依赖性增加,但未减少惊厥小鼠的数量。硝苯地平、氨氯地平(10毫克/千克)和BAY K 8644(2毫克/千克)也使惊厥发作时间增加。(-)-R-202-791(10毫克/千克)对PTZ所致阵挛性惊厥无影响。BAY K 8644增加了死于PTZ所致强直性伸展惊厥的小鼠数量。尼莫地平不影响士的宁引起的惊厥。因此,低剂量的DHP钙拮抗剂具有结构依赖性的抗惊厥特性,而DHP钙通道激活剂可能起到促进惊厥的作用。这些观察结果提示并支持了先前的证据,即DHP受体是惊厥状态的重要调节位点。